Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MLN-518 enters phase I in AML

May 31, 2002

Single-dose palonosetron provides prolonged relief from CINV

May 31, 2002

LymphoRad targets B-cells and B-cell tumors and exerts antitumor activity in preclinical studies

May 31, 2002

Phase I results support further development of ABX-EGF for cancer

May 31, 2002

Potent inhibitor of Jak family protein tyrosine kinases discovered at Merck

May 31, 2002

Early clinical data for DRF-1042 presented at ASCO

May 31, 2002

BMS patent describes DNA topoisomerase I inhibitors

May 31, 2002

Novel antiandrogens in the Yamanouchi pipeline

May 31, 2002

New therapeutic approaches for renal cell carcinoma presented at the AUA meeting

May 31, 2002

Spotlight on topoisomerase inhibitors under development

May 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...